CASI Pharma (CASI) Misses Q3 EPS by 67c

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
• Oracle (ORCL) call put ratio 2.8 calls to 1 put as share price down 3.5%
• Micron Technology (MU) call put ratio 1 call to 1 put as share price down 7.4%